Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sella

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Cancer Biotherapy|January 1, 1995
Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancerA Sella, B B Aggarwal, R G Kilbourn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
Inorganic Chemistry|April 13, 2001
Solid-state structure and solution behavior of eight-coordinate Sm(III) poly(pyrazolyl)borate compoundsI Lopes, A C Hillier, S Y Liu, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
International Immunopharmacology|May 16, 2002
Inhibition of contact hypersensitivity reaction to picryl chloride: effect of small molecular weight peptidomimetic compounds possessing inhibitory activity against metalloproteinasesM Mattei, E Carnieri, V Politi, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
Cancer|November 1, 1993
Primary carcinoid of the kidney. Immunohistochemical and ultrastructural studies of five patientsW F Raslan, J Y Ro, N G Ordonez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Cancer Biotherapy|January 1, 1995
Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancerA Sella, B B Aggarwal, R G Kilbourn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
Inorganic Chemistry|April 13, 2001
Solid-state structure and solution behavior of eight-coordinate Sm(III) poly(pyrazolyl)borate compoundsI Lopes, A C Hillier, S Y Liu, et al.
The Journal of Urology|January 1, 1989
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experienceC J Logothetis, F H Dexeus, C Chong, et al.
International Immunopharmacology|May 16, 2002
Inhibition of contact hypersensitivity reaction to picryl chloride: effect of small molecular weight peptidomimetic compounds possessing inhibitory activity against metalloproteinasesM Mattei, E Carnieri, V Politi, et al.
Urology|July 1, 1991
Serum biomarkers in metastatic renal cell carcinomaF H Dexeus, C J Logothetis, A Sella, et al.
Cancer|November 1, 1993
Primary carcinoid of the kidney. Immunohistochemical and ultrastructural studies of five patientsW F Raslan, J Y Ro, N G Ordonez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumorsC J Logothetis, F H Dexeus, L Finn, et al.
Journal of the National Cancer Institute|April 18, 1990
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factorC J Logothetis, F H Dexeus, A Sella, et al.
Cancer Biotherapy|January 1, 1994
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancerA Sella, R G Kilbourn, I Gray, et al.
Pageof 9